


| Revenue | $100 - $500 million See Exact Annual Revenue |
|---|---|
| Employees | 100 - 500Exact Company Size |
| Primary Industry | 325411 Medicinal & Botanical Manufacturing |
| Additional NAICS Codes | 325414 Biological Product Manufacturing 4234 Professional & Commercial Equipment & Supplies Merchant Wholesalers 5417 Scientific Research & Development Services 541711 Research & Development in Biotechnology |
| Address | 2525 E Nc Highway 54 Durham, NC 27713 |
| Humacyte Global | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $100 - $500 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Humacyte Global P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| SYMVESS Bioengineered tissue; biological implants; biological tissue grafts; vascular grafts; bioengineered blood vessels; biological tissue implants for use in surgery and regenerative medicine; human tissue substitute comprised of material derived from biological tissue | 06/20/2023 |
| HAV Bioengineered tissue; biological implants; biological tissue grafts; vascular grafts; bioengineered blood vessels; biological tissue implants for use in surgery and regenerative medicine; human tissue substitute comprised of material derived from biological tissue | 06/20/2023 |
| LUNA200 Bioengineering services, namely, developing and manufacturing biological tissue; Research and development of bioengineered tissue; Scientific research in the field of bioengineering and regenerative medicine; Providing information in the field of bioengineering and regenerative medicine; Information in the field of bioengineering and regenerative medicine | 05/10/2023 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| XYMOGEN | Orlando, FL | 100 |
| AVANTI NUTRITIONAL LABORATORIES | Miami Lakes, FL | 37 |
| NUTRITION FORMULATORS | Miramar, FL | 36 |
| RTPR | Cabot, AR | 33 |
| INTEGRATED BOTANICS | Fort Worth, TX | 29 |
| COSMAX NBT USA | Garland, TX | 29 |
| CJB INDUSTRIES | Valdosta, GA | 28 |
| ALTERNATIVE LABORATORIES | Naples, FL | 28 |
| S&B PHARMA | Azusa, CA | 28 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| TERGUS PHARMA | Durham, NC | 100 |
| HUMACYTE GLOBAL | Durham, NC | 87 |
| MEDICAGO USA | Durham, NC | 67 |
| BRII BIOSCIENCES | Durham, NC | 51 |
| FENNEC PHARMACEUTICALS | Research Triangle Park, NC | 46 |
| DOVA PHARMACEUTICALS | Durham, NC | 42 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |